Evidence map›Paper›PMID 41458246›Full record

ArticleBMJ neurology open2025

Data-driven targets for predicting outcomes in patients with HIV infection and tuberculous meningitis in China.

Yuwei Li, Yang Zhou, Pengfei Zhao, Yinzhong Shen, Haolan He, Yan Sun, Yanfen Liu, Qingxia Zhao, Yahong Chen, Jianhua Yu and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ neurology open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Yuwei LiBeijing Chest Hospital, Capital Medical University, Beijing, China.
Yang ZhouMolecular Biology Research Centre & Centre for Medical Genetics, Central South University, Changsha, China.
Pengfei ZhaoNational Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, China.
Yinzhong ShenDepartment of Infection and Immunity, Shanghai Public Health Clinical Center, Shanghai, China.
Haolan HeGuangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.
Yan SunThe Sixth People's Hospital of Zhengzhou, Zhengzhou, Henan, China.
Yanfen LiuThe Department of Infection, The Fourth People's Hospital of Nanning, Nanning, Guangxi, China.
Qingxia ZhaoThe Sixth People's Hospital of Zhengzhou, Zhengzhou, Henan, China.
Yahong ChenMengchao Hepatobiliary Hospital, Fujian Medical University, Fuzhou, China.
Jianhua YuXixi Hospital of Hangzhou, Hangzhou, China.
Ping MaTianjin City Second People's Hospital, Tianjin, China.
Zhimin ChenGuangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.
Hui WangNational Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, China.
Mingbin ZhengDepartment of Infection and Immunity, The Third People's Hospital of Shenzhen, Shenzhen, China.
Yaokai ChenDepartment of Infectious Diseases, Chongqing Public Health Medical Center, Chongqing, China.
Min LeiHunan University of Technology, Zhuzhou, China.
Weimin LiBeijing Chest Hospital, Capital Medical University, Beijing, China.ORCID https://orcid.org/0000-0003-2796-9009
Hongzhou LuNational Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: For people living with HIV (PLWH) and tuberculous meningitis (TBM), current studies on risk stratification and poor prognosis lack a clear optimal threshold. To address this gap, this study aims to identify an optimal immunological threshold for risk stratification and explore predictors of poor prognosis in this population. Methods: We conducted a multicentre cross-sectional study enrolling PLWH with TBM from hospitals across eight provinces of China between January 2018 and December 2020. We extracted the demographic and clinical data, discharge outcomes, Medical Research Council staging and CD4 Results: A total of 201 participants were included in the study. Of these, 173 (86.1%) improved with treatment. Restricted cubic spline analysis identified CD4 Conclusions: In PLWH with TBM, a CD4

Indexed as

AIDSTUBERCULOSIS

Identifiers

PMID41458246
PMCPMC12742164

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.